MHRA: April Drug Safety Update on Pregabalin (Lyrica)

Hermione Price, Honorary Secretary ABCD
Date of the announcement: 
Friday, 22 April, 2022


The MHRA has published a Drug Safety Update on pregabalin (Lyrica) and the findings of a safety study on risks if used during pregnancy.

They have also produced a Safety leaflet to help patients to understand the latest information about the effects of pregabalin during pregnancy.

More information about the study

The MHRA will be actively maintaining the patient guidance and will review with our team the need for any updates at 1 month, 6 months and 18 months (as is routine). If you have any further feedback, please send this to where it will be reviewed by the assessment team.

ABCD Webinar Series

ABCD Webinars